Effects of poloxamer 407 on transfection time and percutaneous adenovirus-mediated gene transfer in native and stented vessels

Human Gene Therapy

Volumn 9, Issue 7, 1998, Pages 1013-1024

  Van Belle, Eric ^a   Maillard, Luc ^a   Rivard, Alain ^a   Fabre, Jean Etienne ^a   Couffinhal, Thierry ^a   Kearney, Marianne ^a   Branellec, Didier ^b   Feldman, Laurent J ^a   Walsh, Kenneth ^a   Isner, Jeffrey M ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Gencell   (France)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; POLOXAMER;

ADENOVIRUS; ANIMAL EXPERIMENT; ARTICLE; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; ILIAC ARTERY; NONHUMAN; RABBIT; STENT;

ADENOVIRIDAE; ANIMALIA; ORYCTOLAGUS CUNICULUS; RICE STRIPE VIRUS;

EID: 17344363487     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.7-1013     Document Type: Article

References (11)

1. BARR, E., CARROLL, J., KALYNYCH, A.M., TRIPATHY, S.K., KOZARSKY, K., WILSON, J.M., and LEIDEN, J.M. (1994). Efficient catheter-mediated gene transfer into the heart using replicant-defective adenovirus. Gene Ther. 1, 51-58.
2. CHANG, M.W., BARR, E., JONATHAN, S., JIANG, Y.Q., NABEL, G.J., NABEL, E.G., PARMACEK, M.S., and LEIDEN, J.M. (1995a). Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267, 518-522.
3. CHANG, M.W., BARR, E., LU, M.M., BARTON, K., and LEIDEN, J.M. (1995b). Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J. Clin. Invest. 96, 2260-2268.
4. CHEN, S.J., WILSON, J.M., and MULLER, D.W.M. (1994). Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Circulation 89, 1922-1928.
5. CHENG, L., ZIEGLHOFFER, P.R., and YANG, N.S. (1993). In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardement. Proc. Natl. Acad. Sci. U.S.A. 90, 4455-4459.
6. COLOMBO, A., HALL, P., NAKAMURA, S., ALMAGOR, Y., MAIELLO, L., MARTINI, G., GAGLIONE, A., GOLDBERG, S.L., and TOBIS, J.M. (1995). Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 91, 1676-1688.
7. COUFFINHAL, T., KEARNEY, M., SULLIVAN, A., SILVER, M., TSURUMI, Y., and ISNER, J.M. (1997). Histochemical staining following LacZ gene transfer underestimates transfection efficiency. Hum. Gene Ther. 8, 929-934.
8. FELDMAN, L.J., STEG, P.G., ZHENG, L.P., CHEN, D., KEARNEY, M., MCGARR, S.E., BARRY, J.D., DEDIEU, J.F., PERRICAUDET, M., and ISNER, J.M. (1995). Low efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J. Clin. Invest. 95, 2662-2671.
9. FELDMAN, L.J., TAHLIL, O., and STEG, P.G. (1996). Perspectives of arterial gene therapy for prevention of restenosis. Cardiovasc. Res. 32, 194-207.
10. WILLARD, J.E., LANDAU, C., GLAMANN, B., BURNS, D., JESSEN, M.E., PIRWITZ, M.J., GERARD, R.D., and MEIDELL, R.S. (1994). Genetic modification of the vessel wall: Comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus. Circulation 89, 2190-2197.
11. WU, K.K. (1997). Prostacylin and nitric oxide-related gene transfer in preventing arterial thrombosis and restenosis. Agents Actions Suppl. 48, 107-123.